Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20020006HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20020007HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS44019173HTLV-1ENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TCGA Plot Options
Drug Information
GeneHTR1F
DrugBank IDDB00953
Drug NameRizatriptan
Target IDBE0000460
UniProt IDP30939
Regulation Typeagonist
PubMed IDs11752352; 15320857; 12434581; 9718276; 14614913
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Villalon CM, Centurion D, Valdivia LF, de Vries P, Saxena PR: Migraine: pathophysiology, pharmacology, treatment and future trends. Curr Vasc Pharmacol. 2003 Mar;1(1):71-84.@@Villalon CM, Centurion D, Valdivia LF, De Vries P, Saxena PR: An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proc West Pharmacol Soc. 2002;45:199-210.@@Wainscott DB, Johnson KW, Phebus LA, Schaus JM, Nelson DL: Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation. Eur J Pharmacol. 1998 Jul 3;352(1):117-24.@@Goadsby PJ, Classey JD: Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience. 2003;122(2):491-8.
GroupsApproved
Direct ClassificationTryptamines and derivatives
SMILESCN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
Pathways
PharmGKBPA451264
ChEMBLCHEMBL905